pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
ethacrynate sodium
Ethacrynate Sodium (ethacrynate sodium)
Hepatic Edema
SteriMax Inc
0 catalysts
Marketed
ethacrynic acid
Ethacrynic Acid (ethacrynic acid)
Lymphedema
Agnitio Inc
0 catalysts
Marketed
ethambutol hydrochloride
Myambutol (ethambutol hydrochloride)
Pulmonary Tuberculosis
X-GEN Pharmaceuticals DJB Inc
0 catalysts
← prev
page 210 of 271
next →
131
Pain89
Neurology1
Marketed
ethanolamine oleate
Ethamolin (ethanolamine oleate)
Esophageal Varices
QOL Medical LLC
0 catalysts
Marketed
ethosuximide
Ethosuximide (ethosuximide)
Absence Seizure
Puracap Pharmaceutical LLC
0 catalysts
Phase 2
etigilimab
Adenocarcinoma Of The Gastroesophageal Junction
T-cell immunoreceptor with Ig and ITIM domains
$MREOMereo BioPharma Group plc
0 catalysts
Phase 2
etivelcabtagene erigedleucel
Follicular Lymphoma
Cellectis SA
0 catalysts
Marketed
etodolac
Etodolac (etodolac)
Osteoarthritis Pain
Bayshore Pharmaceuticals LLC
0 catalysts
Marketed
etodolac ER
Etodolac (etodolac)
Osteoarthritis Pain
Unichem Laboratories Ltd
0 catalysts
Marketed
etomidate
Etomidate (etomidate)
General Anesthetic Effect
Caplin Steriles Ltd
0 catalysts
Preclinical
etonogestrel ER
etonogestrel
Female Contraception
Adare Pharmaceuticals Inc
0 catalysts
Preclinical
etonogestrel LA
Nexplanon (etonogestrel)
Female Contraception
Adare Pharmaceuticals Inc
0 catalysts
Marketed
etranacogene dezaparvovec
Hemgenix (etranacogene dezaparvovec)
Hemophilia B (Factor IX Deficiency)
CSL Behring LLC
0 catalysts
Marketed
etrasimod
Velsipity (etrasimod)
Ulcerative Colitis
$PFEPFIZER INC
0 catalysts
Marketed
etripamil
Cardamyst (etripamil)
Atrial Fibrillation
$MISTMilestone Pharmaceuticals Inc.
0 catalysts
Phase 2
evalstotug
evalstotug [INN]
Melanoma
$BCABBioAtla, Inc.
0 catalysts
Phase 2
evarucabgene autoleucel
Refractory Multiple Myeloma
Nexcella Inc
0 catalysts
Phase 3
evenamide
evenamide [INN]
Schizophrenia
Newron Pharmaceuticals SpA
0 catalysts
Marketed
everolimus ODT
Everolimus (everolimus)
Tuberous Sclerosis
Biocon Pharma Ltd
0 catalysts
Preclinical
everolimus SR
everolimus
Hormone Sensitive Breast Cancer
Postsurgical Therapeutics Inc
0 catalysts
Marketed
evolocumab
Repatha (evolocumab)
Atherosclerosis
$AMGNAMGEN INC
0 catalysts
Phase 3
evorpacept
Adenocarcinoma Of The Gastroesophageal Junction
Leukocyte surface antigen CD47
$ALXOALX ONCOLOGY HOLDINGS INC
0 catalysts
Preclinical
exRP-250
Psoriasis
exRNA Therapeutics Ltd
0 catalysts
Phase 3
exagamglogene autotemcel
Casgevy (exagamglogene autotemcel)
Beta Thalassaemia
B-cell lymphoma/leukemia 11A
$VERXVertex, Inc.
0 catalysts
Phase 2
exaluren
exaluren [INN]
Alport Syndrome
$ELOXEloxx Pharmaceuticals, Inc.
0 catalysts
Phase 1
exarafenib
exarafenib [INN]
Melanoma
Laboratoires Pierre Fabre SA
0 catalysts
Phase 1
exenatide
Byetta (exenatide)
Type 2 Diabetes
$ORMPORAMED PHARMACEUTICALS INC.
0 catalysts
Phase 2
exendin-(9-39)
Hyperinsulinemia
Glucagon-like peptide 1 receptor
Children's Hospital of Philadelphia
0 catalysts
Phase 2
exeporfinium chloride
exeporfinium chloride [INN]
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infec…
AMR Bio Ltd
0 catalysts
Phase 2
ezeprogind
ezeprogind [INN]
Progressive Supranuclear Palsy
AlzProtect SAS
0 catalysts